BioSpace News Archive

Microbiome Market | Latest Trends and Cardinal Growth Prospects Report Study

Applications of microbiome in medical sciences have created a plethora of opportunities for growth and advancement within the global market.

March 9, 2021
·
3 min read
Drug Development

First European patients dosed in IRLAB’s Phase IIb/III mesdopetam study

IRLAB announced that the first patients in Europe have been dosed in the clinical Phase IIb/III study with mesdopetam.

March 9, 2021
·
2 min read
Pelvic Congestion Syndrome Treatment Buoyed by Surging Genital Cancer Research

Growing incidences of prostate and ovarian cancers are increasing the frequency of pelvic discomfort, prompting players to introduce advanced surgical and medical treatment alternatives, providing significant traction

March 9, 2021
·
6 min read
Antibiotic Resistance Market: Rising Prevalence of Infections to Bolster the Market

Antimicrobial substances used to combat bacterial infection are termed as antibiotics. They are also used to heal a number of medical conditions like stroke, sinus, urinary tract infections, ear infections, pneumonia, skin infections, and other diseases.

March 9, 2021
·
5 min read
Cognitive Disorders Treatment Market: Rise in prevalence of cognitive disorders to drive the market

Cognitive disorders, also known as neurocognitive disorders, are defined as any disorder that significantly impairs the cognitive function of an individual.

March 9, 2021
·
5 min read
Cold Pain Therapy Market | Growing OTC products are boosting the market growth

Global cold pain therapy market is expected to grow with a CAGR around 3-5% during the forecast period 2020-2030. Rising number of sports injuries and orthopaedic diseases has led to significant growth of the market.

March 9, 2021
·
4 min read
Deals

Hemogenyx Pharmaceuticals PLC Announces Director/PDMR Shareholding

Hemogenyx Pharmaceuticals plc announces that it has been notified that Andrew Wright, the Company’s Financial Controller and Company Secretary, has purchased 94,882 ordinary shares of £0.01 each in the Company at an average price of 6.03p per share.

March 9, 2021
·
2 min read
Business

Checkpoint Therapeutics Reports Full-Year 2020 Financial Results and Recent Corporate Highlights

Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the full-year ended December 31, 2020 and recent corporate highlights.

March 9, 2021
·
9 min read
BioMidwest

R1 RCM to Present at the KeyBanc Life Sciences & MedTech Investor Forum

R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 23 at 10:45am ET.

March 9, 2021
·
1 min read
Business

Five Prime Cancels Fourth Quarter and Full-Year 2020 Financial Results Conference Call

Five Prime Therapeutics, Inc. (NASDAQ: FPRX) announced today that it has canceled its fourth quarter and full year 2020 earnings conference call, which was previously scheduled for Wednesday, March 10, 2021 at 1:30 p.m. PT / 4:30 p.m. ET.

March 9, 2021
·
1 min read